FOCUS AND SCOPE

Folia Medica Indonesiana focuses on these topics but not limited to Anatomy, Histology, Physiology, Biochemistry (medical), Pharmacology (medical), General Neuroscience, Infectious Diseases, Public Health, Enviromental and Occupational. We encourage submission of original research reports, case series with scoping review discussion, and systematic reviews and/or meta-analyses containing basic or applied clinical study i.e. communicable and non-communicable diseases including tuberculosis and COVID-19, diabetes mellitus and cardiovascular diseases, physiology and clinical pathology, development of herbal and other potential phytochemicals, also environmental hazards. Each manuscript submitted must adhere to the checklist accordingly, and it is recommended to follow the checklist from https://www.equator-network.org/reporting-guidelines/, to ensure good manuscript quality and publication. Authors may contact the journal via email in advance to inquire about the suitability of their paper's topic for publication in Folia Medica Indonesiana.

SECTION POLICIES

ORIGINAL RESEARCH REPORT

Open Submissions

Indexed

Peer-Reviewed

CASE SERIES WITH SCOPING REVIEW DISCUSSION

Open Submissions

Indexed

Peer-Reviewed

SYSTEMATIC REVIEW/ META-ANALYSIS

Open Submissions

Indexed

Peer-Reviewed

PUBLICATION FREQUENCY

All articles for Folia Medica Indonesiana are posted online four times a year: in January - March, April - June, July - September, and October - December. All articles will be assigned a Digital Object Identifier (DOI) number, whereby they become searchable and citable without delay.

OPEN ACCESS POLICY

Folia Medica Indonesiana is an Open Access journal under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (CC-BY-NC-SA). The user(s) are free to share, copy and redistribute the material in any medium or format; to adapt, remix, transform, and build upon the material. The licensor cannot revoke these freedoms as long as the user(s) follow the license terms, in which the user(s) must give appropriate credit, provide a link to the license, and indicate if changes were made. The user(s) may do so in any reasonable manner, but not in any way that suggests the licensor endorses the user(s). The user(s) may not use the material for commercial purposes. If the user(s) remix, transform, or build upon the material, the user(s) must distribute the user(s)' contributions under the same license as the original. The user(s) may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

 

 

All articles published in Folia Medica Indonesiana are archived in CLOCKSS to ensure a distributed archiving system among participating libraries, allowing those libraries to create permanent archive of the journal for preservation and restoration. Articles also receive Digital Object Identifiers (DOIs) from the CrossRef organization to guarantee they can always be retrieved.

REFERENCE MANAGER

Every article submitted to Folia Medica Indonesiana shall use reference management software, e.g., EndNote® or Mendeley.

PUBLICATION ETHICS 

Folia Medica Indonesiana adheres to the ethical standards established by the World Association of Medical Editors (WAME) (https://www.wma.net/policy/current-policies/) and the Committee on Publication Ethics (COPE), for all published manuscript containing research on humans and/or using animals models. Folia Medica Indonesiana is committed to maintaining ethical standards and protecting the rights, privacy, and welfare of participants; including for the minority groups if applicable.

This principle also pertains to the use of animal models in research (https://publicationethics.org/case/ethical-standards-animal-research). Universitas Airlangga, the publisher, maintains these standards and guarantees that editorial decisions are impartial. The author(s) and peer-reviewer(s) are both oblivious to the other, ensuring that a submitted manuscript is subjected to a rigorous double-blind peer-review. Folia Medica Indonesiana does not tolerate any form of plagiarisms. We employ https://turnitin.com to evaluate the similarity rate of all submitted manuscripts. A manuscript contains similarity rate of more than 20% will be rejected.

Research Ethics & Consent

All original research articles involving humans, animals, plants, biological materials, protected or non-public datasets, collections, or places must contain a written statement in an Ethics Approval section that includes the following:
- The designation of the ethical committee(s) or institutional review board(s) engaged.
- The identification number or ID of the ethics approval(s).
- A declaration that human subjects have given informed permission prior to their involvement in the research.
- Research involving animals must comply with ethical norms regarding animal care. All original research publications involving animals must adhere to international, national, and institutional regulations regarding the humane treatment of animals.
- Obtain approval from the ethics review committee at the institution or practice where the research was conducted, and include specifics regarding the approval process, the names of the ethics committee(s) or institutional review board(s) involved, and the identification number or ID of the ethics approval(s) in the Ethics Approval section.
- Justify the utilization of animals and the chosen species.
- Furnish details regarding housing, nutrition, environmental enrichment, and measures implemented to mitigate suffering.
- Specify the method of anesthetic and euthanasia.
- Research failing to comply with the aforementioned criteria concerning ethical approval and animal welfare will be disqualified.

All manuscripts including details or photos pertaining to an individual must secure written informed consent for publishing from that individual (or their parent or legal guardian if under 18 years old). Consent is required for the publication of their details under the Creative Commons Attribution License 4.0 (CC-BY-NC-SA), ensuring they are publicly accessible on the internet. Consent for publication must be acquired from the deceased's next of kin. Authors may utilize the consent form to secure permission for publishing, or an other consent form from their respective institution or location if suitable. The consent form must indicate that the details/images will be publicly accessible on the internet and may be viewed by the general populace. The consent form shall be provided upon manuscript submission and will be handled with confidentiality.

a. Research Involving Humans

If the research involve human subjects, the author must assure compliance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for human experimentation. The paper must adhere to the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals and strive for the inclusion of representative human populations regarding sex, age, and ethnicity in accordance with those guidelines. The phrases sex and gender must be utilized accurately. All protocols must have received approval from the authors' institutional or pertinent ethical commission (Institutional Review Board, IRB) to ensure compliance with national and international criteria. Submission of an article must include details of this approval, such as the institution, review board name, and permit number(s). Ethics approval must be secured prior to conducting the research; retrospective approval is typically unattainable, and publication of the work may be infeasible. Authors must add a statement in the publication confirming that informed consent was acquired for testing with human subjects. The privacy rights of human subjects must be consistently upheld.

b. Research Involving Animals

All animal experiments must adhere to the ARRIVE guidelines and be conducted in accordance with the U.K. Animals (Scientific Procedures) Act, 1986, the EU Directive 2010/63/EU for animal experimentation, or the National Research Council's Guide for the Care and Use of Laboratory Animals. Authors must explicitly state in the manuscript that these guidelines have been followed. The sex of animals must be specified, and when relevant, the impact of sex on the study's results should be noted. Experiments with vertebrates or regulated invertebrates must adhere to the ethical criteria established by the authors' institution and applicable national or international regulations. Where relevant, a declaration of ethics approval or animal licenses should be incorporated. In every instance, a declaration must be issued to affirm that all measures were used to alleviate any animal suffering, accompanied by specifics on the methods employed.

c. Research Involving Plants

Research on plants must adhere to the protocols established by the authors' institution and any national or international regulations. Where relevant, a declaration of granted permits or licenses should be incorporated. Authors must adhere to the Convention on Biological Diversity and the Convention on International Trade in Endangered Species of Wild Fauna and Flora.

 

Duties of Editors

Publication Decisions

The editorial board has the authority to decide which submitted articles will be published. This decision is informed by reviewer recommendations and thorough deliberation while ensuring compliance with legal standards, such as those regarding libel, copyright infringement, and plagiarism. Importantly, editorial decisions are free from biases related to the authors' nationality, ethnicity, political beliefs, race, or religion, ensuring an equitable process for all submissions.

Confidentiality and Conflicts of Interest

Editors are responsible for maintaining the confidentiality of all manuscripts submitted for review. Information regarding a submission must only be shared with the corresponding author, reviewers, potential reviewers, and editorial advisors as necessary. Any unpublished material disclosed in a manuscript must not be used for an editor’s personal research without the explicit written permission of the author. Furthermore, readers should be informed about the funding sources of the research and any role the funders played in the research process or publication, ensuring transparency in potential conflicts of interest.

Author and Reviewer Relations

Editors are tasked with ensuring that the peer-review process is conducted fairly, impartially, and in a timely manner. Special measures are implemented to ensure unbiased handling of submissions from editorial board members. Reviewer feedback is shared with authors in full unless it contains offensive or defamatory content. Editors recognize the contributions of reviewers and discontinue the services of those who consistently provide poor-quality, discourteous, or delayed reviews.

Quality Assurance

Editors are committed to publishing accurate, high-quality content. This includes verifying that research involving human or animal subjects has received approval from appropriate ethics committees. Intellectual property concerns, such as copyright violations or plagiarism, are rigorously addressed. Errors, inaccuracies, or misleading claims in published work are corrected promptly to uphold the journal's credibility.

 

Duties of Reviewers

Editorial Contributions

Reviewers play a key role in assisting the editorial board in making publication decisions. Their reviews should be objective, constructive, and focused on improving the manuscript. Personal criticism of the authors is inappropriate and discouraged.

Qualifications and Conflicts of Interest

Reviewers must decline invitations to review if they feel unqualified to evaluate the research or if they are unable to meet the deadline. Additionally, reviewers should not evaluate manuscripts where they have conflicts of interest, such as financial, collaborative, or other relationships with the authors, institutions, or companies involved.

Confidentiality and Source Recognition

Manuscripts under review must be treated as confidential documents and should not be disclosed or used for personal gain. Reviewers are expected to identify relevant published works not cited by the authors and ensure proper attribution is made. Any significant overlap or similarity with other published works should be reported to the editor.

 

Duties of Authors

Accurate Reporting and Originality

Authors are required to provide a clear and accurate report of their research, presenting an objective discussion of its significance. Data must be presented truthfully, and authors should be prepared to provide public access to raw data for a minimum of two years post-publication. Work must be entirely original, with proper acknowledgment given to the ideas or work of others. Plagiarism, in any form, is unethical and unacceptable, as is submitting the same work to multiple journals simultaneously.

Conflicts of Interest and Author Attribution

All authors must disclose any financial or other conflicts of interest that might influence the interpretation of their findings. The corresponding author is responsible for ensuring that all contributors who meet authorship criteria are appropriately listed and that all co-authors have reviewed and approved the final manuscript before submission. Contributions by individuals who do not qualify as authors should be properly acknowledged.

Error Correction

If an author discovers a significant error or inaccuracy in their published work, they must promptly notify the journal editor and cooperate to issue a correction or retraction as necessary. This obligation ensures the integrity and reliability of the academic record.

 

COMMENTS AND COMPLAINTS

If readers have any concerns or complaints regarding published articles, we encourage them to first reach out to the corresponding author in an attempt to resolve the issue directly, prior to contacting the editorial office.

If it is impractical to contact the authors directly, if they are unresponsive, or if the issues persist unresolved, readers are encouraged to contact the editorial office. Upon receipt of such communications, the editorial office will engage with the complainant, the author(s), as well as the editor-in-chief or members of the editorial board to thoroughly investigate, discuss, and resolve any concerns or grievances raised.

Any complaints, comments, or requests for updates pertaining to the scholarly integrity, ethical considerations, or legal aspects of the published article or its peer review process will be carefully examined as necessary. The editorial office, in collaboration with the editorial board and under the final approval of the editor-in-chief, will conduct comprehensive investigations in line with publication ethics guidelines established by COPE. Additional consultations with relevant parties, such as university officials or specialists, may be sought as appropriate, especially in cases involving legal implications.

It is important to note that personal opinions or critiques will not be considered. All complaints, including those submitted anonymously, will be thoroughly assessed. Should complainants wish to discuss their concerns confidentially, they are encouraged to request such discussions with the editorial office. According to internal procedures, confidentiality will be maintained to the best of our ability.

Decisions regarding corrections, comments and replies, expressions of concerns, or retractions resulting from investigations will be made by the editor-in-chief, section editor, or editorial board members and communicated to the authors accordingly. 

In cases where complaints are found to be unsubstantiated, further communication will only be entertained upon presentation of additional evidence supporting the concerns raised.

During an inquiry, complainants may not receive updates on the investigation's progress until a final decision is reached. However, they will be promptly informed of any new developments. Please keep in mind that members of the editorial board and editorial office are not obligated to provide additional information. Communication may be terminated if discussions deviate from respectful and constructive dialogue. Readers are advised that conducting inquiries is a meticulous process that demands careful consideration and time.

 

POTENTIAL CONFLICTS OF INTEREST

All authors are obligated to disclose any actual or potential conflict of interest, including any financial, personal, or other relationships with other individuals or organizations that could inappropriately influence, or be perceived to influence, their work. Folia Medica Indonesiana follows the guidelines about conflict of interest as stated in https://publicationethics.org/competinginterests.

 

CORRECTION, CONCERN, AND RETRACTION

Sometimes after an article has been published it may be necessary to make a change to the published article. This will be done after careful consideration by the Editor to ensure any necessary changes are done in accordance with guidance from the Committee on Publication Ethics (COPE). Any necessary modifications will be accompanied by a post-publication announcement that will be permanently linked to the original piece. This may manifest as a correction notice (Corrigendum or Erratum), an Expression of Concern, a Retraction, or, in exceptional cases, a Removal. The objective of this approach for implementing permanent and transparent changes is to uphold the integrity of the scholarly record.

A correction note will be given when it is required to rectify an error or omission that may affect the interpretation of the article, while preserving the scholarly integrity of the work. Examples encompass the mislabeling of a figure, the omission of information regarding financing, or the absence of disclosures concerning the authors' competing interests. The journal employs two kind of correction notices: a Corrigendum is generally issued for errors made by the authors, while an Erratum is typically issued for errors made by the publisher. X

A retraction notice will be issued when a significant error (e.g., in analysis or methodology) undermines the article's conclusions, or when research or publication misconduct occurs (e.g. fabricating data, manipulating images, plagiarism, duplicate publication, etc.). The determination to retract an item will be made in compliance with COPE principles (https://publicationethics.org/retraction-guidelines). Authors and institutions may request the retraction of their articles if their justifications satisfy the grounds for retraction. All retractions published in the journal will guarantee that the retraction and the original article are interconnected in both directions. The retracted article is distinctly identified. The original HTML version will persist, with both the HTML and PDF formats of the original article digitally marked as 'Retracted.'

A coherent rationale for the retraction is presented. Retractions are typically not granted to address authorship issues. The optimal course of action in this scenario is to issue a corrigendum. This is contingent upon the authors' ability to substantiate the alteration in authorship, which typically necessitates endorsement from their respective institutions. To mitigate the effects of erroneous or deceptive publications, all endeavors will be undertaken to publish retractions promptly.

An Expression of Concern notice may be warranted when significant issues, such as serious research or publication misconduct, have been identified, yet the investigation's outcome remains inconclusive or is delayed due to various complexities. Upon completion of the investigation, a Retraction or Correction notice may be issued subsequent to the Expression of Concern, and both will remain integral to the permanent published record alongside the original item.

A Removal notice will be given only in exceptional situations when issues cannot be resolved by a Retraction or Correction notice. Examples encompass instances where the article's content is libelous, violates legal rights, or is subject to a court order. In any case of redundant publication, Folia Medica Indonesiana follows the guidelines as stated in: https://publicationethics.org/resources/flowcharts/suspected-redundant-publication-published-manuscript.

 

CONFIDENTIALITY

A submitted manuscript is confidential content. Folia Medica Indonesiana will not reveal submitted papers to anybody other than those involved in the processing and preparation of the manuscript for publication, contingent upon acceptance. This group comprises editorial personnel, corresponding authors, prospective reviewers, current reviewers, and editors. In instances of alleged misconduct, a manuscript may be disclosed to members of the ethical committees of Universitas Airlangga as the publisher of Folia Medica Indonesiana for the settlement of the misbehavior. Folia Medica Indonesiana adheres to the relevant COPE flowcharts (https://publicationethics.org/resources/flowcharts/risk-published-data; https://publicationethics.org/news-opinion/new-flowcharts-ethical-concerns-data-publication) as required.

 

MISCONDUCT

The journal regards all types of misconduct with utmost seriousness and will implement all requisite measures, in alignment with COPE recommendations, to safeguard the integrity of the scholarly record.
Instances of misbehavior encompass (but are not confined to):
• Misrepresentation of affiliation
• Violations of copyright/unauthorized use of third-party materials
• Citation manipulation
• Duplicate submission/publication
• "Ethics dumping"
• Image or data modification/fabrication
• Manipulation of peer review
• Plagiarism
• Text recycling/self-plagiarism
• Undisclosed conflicts of interest
• Unethical research practices

a. Duplicate Submission*)

Manuscripts identified as already published or currently under review elsewhere will face penalty for duplicate submission/publication. Authors must cite their own previously published work or work presently under review if it serves as the foundation for a submitted manuscript, and they must explain how the submitted manuscript provides novel contributions beyond the prior work. 

b. Citation Manipulation

Manuscripts submitted that contain citations primarily intended for increasing the citation count of a certain author's work or papers published in a particular journal will face penalty for citation manipulation.

c. Data Fabrication

Manuscripts submitted that contain faked or falsified experimental results, including picture manipulation, will face fines for data fabrication and falsification. 

d. Improper Authorship

All mentioned authors must have made a substantial scientific contribution to the research in the publication and endorsed all its assertions. It is essential to enumerate all individuals who made substantial scientific contributions, including students and laboratory personnel. Further explanation as stated in Instructions for Authors.

e. Redundant Publications

Redundant publications involve the improper segmentation of research findings into many articles. 

f. Image Manipulation

Intentional measures employed to improperly alter or falsify an image constitutes a serious kind of wrongdoing intended to deceive others and undermine the integrity of the scholarly record, resulting in extensive and enduring repercussions. The journal mandates that all photographs in articles must be precise and unaltered. Specific elements within a picture must not be improved, disguised, relocated, eliminated, or inserted without proper notification of the alteration. Modifications to the brightness, contrast, or color balance of an image are permissible provided they do not obscure, remove, or mislead the information contained in the original. The organization of figures or the accompanying figure legend must clearly indicate the grouping of images from various sections of gels, western blots, or microscopy images. If the original, unaltered photographs cannot be provided upon request by the journal, the acceptance of a manuscript or paper may be refused or withdrawn.

 

PEER REVIEW PROCESS

All manuscripts are subjected to peer-review and are expected to meet the standards of academic excellence. If approved by the Editorial Board, submissions will be considered by peer-reviewers, whose identities will remain anonymous to the authors and vice versa (double-blind peer-review). The decision regarding the acceptance or rejection of a manuscript is the responsibility of the Editorial Board and is based on the recommendations of the reviewers (peer-reviewed process). Our Editorial Board will occasionally seek advice outside standard peer-review, for example, on submissions with serious ethical, security, biosecurity, or societal implications. We may consult experts and the external academic reviewer(s) before deciding on appropriate actions, including but not limited to recruiting reviewers with specific expertise, assessment by the Editorial Board and declining to further consider a submission.

ARTICLE PROCESSING CHARGE

The article processing charge (APC) for publication in Folia Medica Indonesiana is IDR 1.5 million (Virtual Account: Bank Negara Indonesia 9883030300000386). Payment is due after the manuscript is accepted for publication in the journal. The journal does not require any submission charges.

Waiver Policy
Any request for a waiver of APC will be considered only when the Corresponding Author has emailed The Editor in-Chief via fmi@journal.unair.ac.id prior to the review process. Please include supporting evidence for the reason of the waiver and include details of:
1.The affiliation and country of residence of all authors.
2. Details of the research location.
3. The written proof of the study funding.
If you have already accepted a discounted price offered to you at the time of submission, please be aware that this is the maximum discount, and we are unable to assist you further.
Authors who receive support from, or are employed by, a commercial organization (e.g., a pharmaceutical company) will not be eligible to receive this discounted price. They will be required to pay the full advertised price in effect at the time of submission.
The waiver request form can be downloaded here.

PLAGIARISM CHECK

Folia Medica Indonesiana enforces a strict rule against plagiarism, prohibiting the use of others' ideas, words, or labor without proper attribution. Submissions that exhibit plagiarism in any form, duplicate or repetitive publishing, or self-plagiarism (in the same or a different language) will be rejected. The corresponding author is accountable for the manuscript during and after the evaluation and publication processes, possessing the authority to represent all co-authors. Manuscripts exhibiting an unacceptable similarity index due to plagiarism are promptly rejected. 

EXTERNAL LINKS

Folia Medica Indonesiana is now collaborating with the Unit of Journal Consortium and Folia Medica Indonesiana (UKJF), Faculty of Medicine, Universitas Airlangga. The information can be accessed via an external link: https://ukjf.fk.unair.ac.id/.

REPOSITORY POLICY

Folia Medica Indonesiana allows authors to deposit all versions of their work. This policy sets out the ways in which authors of Folia Medica Indonesiana can self-archive versions of their work in their own web pages, institutional web pages, and another repository. Further explanation can be seen in the table below.

Article Version	Personal Website	Institutional or Non-Commercial Subject-Based Repository	Commercial Platforms and Social Media
Author Original Version (AOV)	At any time	At any time	At any time
Accepted Manuscript (AM)	At any time	At any time	At any time
Version of Record (VOR)	At any time	At any time	At any time